FDA Orange Book · active-ingredient family
Trimeprazine tartrate
Trimeprazine tartrate is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:TEMARIL · NDA 011316
1
Brand (NDA)
2
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule, extended release, syrup, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TEMARIL×3 | ALLERGAN HERBERT | NDA 011316 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (2)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TRIMEPRAZINE TARTRATE | MORTON GROVE | ANDA 088285 | — | Apr 11, 1985 | |
| TRIMEPRAZINE TARTRATE | ALPHARMA US PHARMS | ANDA 085015 | — | Feb 18, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Trimeprazine tartrate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

